My husband says I come from a long line of criers. I think a good cry (and good literature) is worth it sometimes. I'd love to hear your thoughts, though.
"The Cancer Research UK study found that when these immune cells were present, survival improved for women with ER-negative and ER-positive HER2-postive breast cancer."
"“Just a few years ago, median survival for patients diagnosed with advanced melanoma was as little as a year or less, and only approximately 20-25 percent survived two years, so it’s truly remarkable that we’re seeing a median survival over three years in this trial,” said lead study author Mario Sznol, MD, a professor of medical oncology at Yale School of Medicine in New Haven, CT."
"ASCO chose to highlight the findings because [this drug] is already approved by the Food and Drug Administration for use against a different blood cancer called mantle cell lymphoma, as well as for chronic lymphocytic leukemia.That means cancer specialists can start offering it to their patients right away."
I love news like this.
"The drugs are already being used in clinical trials and have been granted Breakthrough Therapy status by the Federal Drugs Agency in the US, which means their development has been speeded up.They could be available within just a few years if approved by European regulators and the National Institute of Clinical Excellence."
Have I mentioned I love news like this?
Sadly, this argument does not work on my 3-year-old (although he doesn't care for most red meat, either).
It's not chronic for enough of us, the way diabetes or heart disease is, in part because the side effects of cancer treatment can be crippling for many. But we are making strides, and I maintain hope that more significant advances are on the horizon. I'm banking on it.